NPM1 and acute myeloid leukemia: Interestingly, Greiner et al., recently performed flow-cytometry and microarray analyses on a total of 30 AML samples, including 15 cases with NPM1 mutations, to assess PD-L1 expression in leukemic cells at diagnosis [17,70].